The performance of companies tied to iconic drugs like Viagra presents a challenging investment scenario . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the patent expiration in key territories has introduced significant volatility. Investors are now grappling with the consequences